Innoviva Balance Sheet
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innoviva financial position
At the end of fiscal 2025, Innoviva reported total assets of $1.64 billion, up 25.7% from a year earlier against total liabilities of $462.3 million. Shareholders' equity stood at $1.17 billion, or 71.7% of assets. The company held $550.9 million in cash and equivalents against $257.7 million of debt, a net cash position of $293.2 million.
The current ratio (current assets divided by current liabilities) was 14.64, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.22.
Summary generated from market data by MetaCap's automated system. Methodology
Innoviva balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 550.94M | 304.96M | 193.51M | 291.05M | 201.53M | 246.49M | 278.10M | 62.42M | 73.34M | 118.02M |
| Short-Term Investments | — | — | — | — | 0 | 0 | 72.75M | 52.49M | 55.74M | 32.42M |
| Inventory | 39.17M | 33.73M | 40.74M | 55.90M | 0 | — | — | — | — | — |
| Total Current Assets | 727.51M | 554.31M | 344.22M | 443.51M | 313.67M | 342.06M | 431.23M | 199.04M | 200.37M | 198.05M |
| Property, Plant & Equipment | 1.55M | 514.00K | 483.00K | 170.00K | 12.00K | 28.00K | 33.00K | 160.00K | 209.00K | 368.00K |
| Goodwill | 17.91M | 17.91M | 17.91M | 26.71M | 0 | — | — | — | — | — |
| Intangible Assets | 182.16M | 208.43M | 230.34M | 252.92M | 0 | — | — | — | — | — |
| Long-Term Investments | 404.50M | 341.66M | 444.43M | 363.86M | 483.85M | 438.26M | 0 | — | — | — |
| Total Assets | 1.64B | 1.30B | 1.24B | 1.23B | 926.39M | 999.57M | 724.83M | 548.19M | 367.34M | 379.00M |
| Accounts Payable | 4.97M | 2.13M | 6.72M | 2.94M | 27.00K | 66.00K | 10.00K | 11.00K | 601.00K | 128.00K |
| Short-Term Debt | 0 | 192.03M | 0 | 96.19M | 0 | — | — | — | — | 7.75M |
| Total Current Liabilities | 49.70M | 236.08M | 38.13M | 134.97M | 5.81M | 6.11M | 5.37M | 5.70M | 34.74M | 20.05M |
| Long-Term Debt | 257.73M | 256.32M | 446.23M | 444.18M | 394.65M | 385.52M | 377.12M | 382.86M | 574.36M | 708.34M |
| Total Liabilities | 462.32M | 609.90M | 568.55M | 665.71M | 400.46M | 391.73M | 382.71M | 389.14M | 610.04M | 731.99M |
| Shareholders' Equity | 1.17B | 691.16M | 674.96M | 565.79M | 414.74M | 539.91M | 313.50M | 153.58M | -242.86M | -352.99M |
| Retained Earnings | 269.37M | -1.80M | -25.19M | -204.91M | -456.15M | -722.00M | -946.40M | -1.10B | -1.50B | -1.63B |
| Total Debt | 257.73M | 448.34M | 446.23M | 540.37M | 394.65M | 385.52M | 377.12M | 382.86M | 574.36M | 716.09M |
| Net Cash (Debt) | 293.21M | -143.38M | -252.72M | -249.32M | -193.13M | -139.03M | -26.27M | -267.95M | -445.29M | -565.66M |
| Shares Outstanding | 74.64M | 62.66M | 63.31M | 69.19M | 69.57M | 101.39M | 101.29M | 101.10M | — | — |
This table shows 10 annual periods of Innoviva's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INVA's reporting calendar. What is a balance sheet?